STRO

SUTRO BIOPHARMA, INC.

STRO · CIK 1382101 · Annual (10-K) · Last 7 years

Financial Trends

Revenue$62M
20182024
Net Income−$227M
20182024
Operating CF−$192M
20182024
Free Cash Flow
20182024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.1B$0.2B$0.1B$0.1B$0.0B$0.0B$0.0B
Cost of Revenue———————
Gross Profit———————
R&D Expense$0.3B$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B
SG&A Expense———————
Operating Income$-0.2B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B
Net Income$-0.2B$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B
EPS (Basic)$-2.96$-1.78$-2.35—$-1.48——
EPS (Diluted)$-2.96$-1.78$-2.35—$-1.48——

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.4B$0.5B$0.4B$0.3B$0.4B$0.2B$0.2B
Current Assets$0.3B$0.4B$0.4B$0.2B$0.4B$0.1B$0.2B
Cash & Equivalents$0.2B$0.1B$0.0B$0.0B$0.2B$0.0B$0.1B
Total Liabilities$0.3B$0.3B$0.2B$0.1B$0.1B$0.1B$0.1B
Current Liabilities$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.1B$0.2B$0.3B$0.3B$0.1B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$-0.2B$-0.1B$0.0B$-0.1B$-0.1B$-0.1B$0.0B
Investing Cash Flow$0.2B$-0.0B$-0.0B$-0.1B$0.0B$-0.1B$-0.1B
Capital Expenditures——————$0.0B
Financing Cash Flow$0.1B$0.1B$0.0B$0.0B$0.3B$-0.0B$0.2B
← Companies